Literature DB >> 28683294

Similarities and Distinctions of Cancer and Immune Metabolism in Inflammation and Tumors.

Gabriela Andrejeva1, Jeffrey C Rathmell2.   

Abstract

It has been appreciated for nearly 100 years that cancer cells are metabolically distinct from resting tissues. More recently understood is that this metabolic phenotype is not unique to cancer cells but instead reflects characteristics of proliferating cells. Similar metabolic transitions also occur in the immune system as cells transition from resting state to stimulated effectors. A key finding in immune metabolism is that the metabolic programs of different cell subsets are distinctly associated with immunological function. Further, interruption of those metabolic pathways can shift immune cell fate to modulate immunity. These studies have identified numerous metabolic similarities between cancer and immune cells but also critical differences that may be exploited and that affect treatment of cancer and immunological diseases.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  T cell; antitumor immunity; glycolysis; inflammation; macrophage; mitochondria; tumor metabolism; tumor microenvironment

Mesh:

Year:  2017        PMID: 28683294      PMCID: PMC5555084          DOI: 10.1016/j.cmet.2017.06.004

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  302 in total

Review 1.  CD28-mediated co-stimulation: a quantitative support for TCR signalling.

Authors:  Oreste Acuto; Frédérique Michel
Journal:  Nat Rev Immunol       Date:  2003-12       Impact factor: 53.106

2.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

3.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

Authors:  Ruoning Wang; Christopher P Dillon; Lewis Zhichang Shi; Sandra Milasta; Robert Carter; David Finkelstein; Laura L McCormick; Patrick Fitzgerald; Hongbo Chi; Joshua Munger; Douglas R Green
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

4.  GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

Authors:  David H Munn; Madhav D Sharma; Babak Baban; Heather P Harding; Yuhong Zhang; David Ron; Andrew L Mellor
Journal:  Immunity       Date:  2005-05       Impact factor: 31.745

5.  Atg7 Overcomes Senescence and Promotes Growth of BrafV600E-Driven Melanoma.

Authors:  Xiaoqi Xie; Ju Yong Koh; Sandy Price; Eileen White; Janice M Mehnert
Journal:  Cancer Discov       Date:  2015-02-11       Impact factor: 39.397

Review 6.  MYC, Metabolism, and Cancer.

Authors:  Zachary E Stine; Zandra E Walton; Brian J Altman; Annie L Hsieh; Chi V Dang
Journal:  Cancer Discov       Date:  2015-09-17       Impact factor: 39.397

7.  De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells.

Authors:  Luciana Berod; Christin Friedrich; Amrita Nandan; Jenny Freitag; Stefanie Hagemann; Kirsten Harmrolfs; Aline Sandouk; Christina Hesse; Carla N Castro; Heike Bähre; Sarah K Tschirner; Nataliya Gorinski; Melanie Gohmert; Christian T Mayer; Jochen Huehn; Evgeni Ponimaskin; Wolf-Rainer Abraham; Rolf Müller; Matthias Lochner; Tim Sparwasser
Journal:  Nat Med       Date:  2014-10-05       Impact factor: 53.440

Review 8.  Mitochondrial reactive oxygen species and cancer.

Authors:  Lucas B Sullivan; Navdeep S Chandel
Journal:  Cancer Metab       Date:  2014-11-28

9.  Fatty acid carbon is essential for dNTP synthesis in endothelial cells.

Authors:  Sandra Schoors; Ulrike Bruning; Rindert Missiaen; Karla Cs Queiroz; Gitte Borgers; Ilaria Elia; Annalisa Zecchin; Anna Rita Cantelmo; Stefan Christen; Jermaine Goveia; Ward Heggermont; Lucica Goddé; Stefan Vinckier; Paul P Van Veldhoven; Guy Eelen; Luc Schoonjans; Holger Gerhardt; Mieke Dewerchin; Myriam Baes; Katrien De Bock; Bart Ghesquière; Sophia Y Lunt; Sarah-Maria Fendt; Peter Carmeliet
Journal:  Nature       Date:  2015-04-01       Impact factor: 49.962

10.  Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress.

Authors:  Zachary T Schug; Barrie Peck; Dylan T Jones; Qifeng Zhang; Shaun Grosskurth; Israt S Alam; Louise M Goodwin; Elizabeth Smethurst; Susan Mason; Karen Blyth; Lynn McGarry; Daniel James; Emma Shanks; Gabriela Kalna; Rebecca E Saunders; Ming Jiang; Michael Howell; Francois Lassailly; May Zaw Thin; Bradley Spencer-Dene; Gordon Stamp; Niels J F van den Broek; Gillian Mackay; Vinay Bulusu; Jurre J Kamphorst; Saverio Tardito; David Strachan; Adrian L Harris; Eric O Aboagye; Susan E Critchlow; Michael J O Wakelam; Almut Schulze; Eyal Gottlieb
Journal:  Cancer Cell       Date:  2015-01-12       Impact factor: 31.743

View more
  103 in total

Review 1.  Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy.

Authors:  Jackie E Bader; Kelsey Voss; Jeffrey C Rathmell
Journal:  Mol Cell       Date:  2020-06-18       Impact factor: 17.970

Review 2.  Metabolic Barriers to T Cell Function in Tumors.

Authors:  Ayaka Sugiura; Jeffrey C Rathmell
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

Review 3.  The Tumor Metabolic Microenvironment: Lessons from Lactate.

Authors:  Juan C García-Cañaveras; Li Chen; Joshua D Rabinowitz
Journal:  Cancer Res       Date:  2019-06-06       Impact factor: 12.701

Review 4.  Mitochondrial Metabolism as a Target for Cancer Therapy.

Authors:  Karthik Vasan; Marie Werner; Navdeep S Chandel
Journal:  Cell Metab       Date:  2020-07-14       Impact factor: 27.287

Review 5.  Fueling the Revolution: Targeting Metabolism to Enhance Immunotherapy.

Authors:  Robert D Leone; Jonathan D Powell
Journal:  Cancer Immunol Res       Date:  2021-03       Impact factor: 11.151

6.  Imaging mass spectrometry reveals heterogeneity of proliferation and metabolism in atherosclerosis.

Authors:  Christelle Guillermier; Sean P Doherty; Adam G Whitney; Vladimir R Babaev; MacRae F Linton; Matthew L Steinhauser; Jonathan D Brown
Journal:  JCI Insight       Date:  2019-06-06

7.  Prognostic significance of the Controlling Nutritional Status (CONUT) score in surgically treated breast cancer patients.

Authors:  Zhang-Zan Huang; Chen-Ge Song; Jia-Jia Huang; Wen Xia; Xi-Wen Bi; Xin Hua; Zhen-Yu He; Zhong-Yu Yuan
Journal:  Gland Surg       Date:  2020-10

Review 8.  Regulation of macrophage immunometabolism in atherosclerosis.

Authors:  Graeme J Koelwyn; Emma M Corr; Ebru Erbay; Kathryn J Moore
Journal:  Nat Immunol       Date:  2018-05-18       Impact factor: 25.606

Review 9.  Competitive glucose metabolism as a target to boost bladder cancer immunotherapy.

Authors:  Julieta Afonso; Lúcio L Santos; Adhemar Longatto-Filho; Fátima Baltazar
Journal:  Nat Rev Urol       Date:  2020-01-17       Impact factor: 14.432

Review 10.  Metabolism as a guiding force for immunity.

Authors:  Jonathan Jung; Hu Zeng; Tiffany Horng
Journal:  Nat Cell Biol       Date:  2019-01-02       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.